We are analyzing https://link.springer.com/article/10.1007/s00432-024-05641-5.

Title:
Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review | Journal of Cancer Research and Clinical Oncology
Description:
Copper is a necessary micronutrient for maintaining the well-being of the human body. The biological activity of organic ligands, especially their anticancer activity, is often enhanced when they coordinate with copper(I) and (II) ions. Copper and its compounds are capable of inducing tumor cell death through various mechanisms of action, including activation of apoptosis signaling pathways by reactive oxygen species (ROS), inhibition of angiogenesis, induction of cuproptosis, and paraptosis. Some of the copper complexes are currently being evaluated in clinical trials for their ability to map tumor hypoxia in various cancers, including locally advanced rectal cancer and bulky tumors. Several studies have shown that copper nanoparticles can be used as effective agents in chemodynamic therapy, phototherapy, hyperthermia, and immunotherapy. Despite the promising anticancer activity of copper-based compounds, their use in clinical trials is subject to certain limitations. Elevated copper concentrations may promote tumor growth, angiogenesis, and metastasis by affecting cellular processes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Health & Fitness
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

copper, google, scholar, cells, cancer, pubmed, cas, complexes, cell, tumor, dna, activity, therapy, complex, copperii, nanoparticles, study, compounds, showed, central, apoptosis, potential, anticancer, treatment, ros, chem, death, tumors, studies, effects, wang, liu, effect, abdolmaleki, shown, fig, compared, cytotoxicity, human, growth, copperbased, cuproptosis, group, inorg, agents, binding, ions, synthesis, cytotoxic, levels,

Topics {✒️}

hypoxia-inducible factor-1alpha expression cu-cy + x-ray groups illustrated cu-cy-based pdt elicits nir-activated cus nano-platform enhanced chemodynamic/ion-interference therapy platelet-derived growth factor hk–cu-induced cell death cu-cy + x-ray group hypoxia-inducible factor-1 activity achieve receptor-mediated targeting full size image showed keto-enol equilibria hyperthermia-based anti-cancer treatments nonsteroidal anti-inflammatory agents cell lines sh-sy5y short-term kaempferol exposure lonidamine-conjugated ligands designed directing macrophage-mediated immunotherapy synergistic photodynamic/photothermal therapy x-ray crystal structures isatin-schiff base copper anti-human lung cancer cox-2-negative cell line transition metal-based nanomaterials tetra-nuclear complex derived copper-doped carbon dots enzyme-engineered nonporous copper pet-based human biodistribution x-ray crystal structure potent anti-angiogenic activity reported cu-doped polypyrrole transition-metal norharmane compounds article download pdf dual-targeting biomimetic delivery cu-cy-based pdt cox-2-positive cell line 5-formyl-uracil-tsc ligand diffuse high-grade glioma cd44-overexpressing cancer cells cu-cy-mediated pdt pdgfb/pdgfrbeta signaling system 18f-choline pet/ct f-choline pet/ct multi-tyrosine kinase inhibitor 18f-choline pet/mri table 1 copper-based compounds f-choline pet/mri applied fe-chelating agent copper-mediated chemodynamic therapy lymph node-based staging

Questions {❓}

Bisaglia M, Bubacco L (2020) Copper Ions and Parkinson’s disease: why is homeostasis so relevant?
Cantiello F, Crocerossa F, Cascini GL, Russo GI, Ferro M, Cimino S, Lucarelli F, Damiano R (2021) 64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
         description:Copper is a necessary micronutrient for maintaining the well-being of the human body. The biological activity of organic ligands, especially their anticancer activity, is often enhanced when they coordinate with copper(I) and (II) ions. Copper and its compounds are capable of inducing tumor cell death through various mechanisms of action, including activation of apoptosis signaling pathways by reactive oxygen species (ROS), inhibition of angiogenesis, induction of cuproptosis, and paraptosis. Some of the copper complexes are currently being evaluated in clinical trials for their ability to map tumor hypoxia in various cancers, including locally advanced rectal cancer and bulky tumors. Several studies have shown that copper nanoparticles can be used as effective agents in chemodynamic therapy, phototherapy, hyperthermia, and immunotherapy. Despite the promising anticancer activity of copper-based compounds, their use in clinical trials is subject to certain limitations. Elevated copper concentrations may promote tumor growth, angiogenesis, and metastasis by affecting cellular processes.
         datePublished:2024-04-25T00:00:00Z
         dateModified:2024-04-25T00:00:00Z
         pageStart:1
         pageEnd:37
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00432-024-05641-5
         keywords:
            Copper-based compounds
            Copper nanoparticles
            Anticancer activity
            Apoptosis
            Angiogenesis
            Oncology
            Cancer Research
            Internal Medicine
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig9_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig10_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig11_HTML.png
         isPartOf:
            name:Journal of Cancer Research and Clinical Oncology
            issn:
               1432-1335
            volumeNumber:150
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sara Abdolmaleki
               affiliation:
                     name:The University of Georgia
                     address:
                        name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Alireza Aliabadi
               affiliation:
                     name:Kermanshah University of Medical Sciences
                     address:
                        name:Pharmaceutical Sciences Research Center, Health Institute, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Samad Khaksar
               affiliation:
                     name:The University of Georgia
                     address:
                        name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
      description:Copper is a necessary micronutrient for maintaining the well-being of the human body. The biological activity of organic ligands, especially their anticancer activity, is often enhanced when they coordinate with copper(I) and (II) ions. Copper and its compounds are capable of inducing tumor cell death through various mechanisms of action, including activation of apoptosis signaling pathways by reactive oxygen species (ROS), inhibition of angiogenesis, induction of cuproptosis, and paraptosis. Some of the copper complexes are currently being evaluated in clinical trials for their ability to map tumor hypoxia in various cancers, including locally advanced rectal cancer and bulky tumors. Several studies have shown that copper nanoparticles can be used as effective agents in chemodynamic therapy, phototherapy, hyperthermia, and immunotherapy. Despite the promising anticancer activity of copper-based compounds, their use in clinical trials is subject to certain limitations. Elevated copper concentrations may promote tumor growth, angiogenesis, and metastasis by affecting cellular processes.
      datePublished:2024-04-25T00:00:00Z
      dateModified:2024-04-25T00:00:00Z
      pageStart:1
      pageEnd:37
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00432-024-05641-5
      keywords:
         Copper-based compounds
         Copper nanoparticles
         Anticancer activity
         Apoptosis
         Angiogenesis
         Oncology
         Cancer Research
         Internal Medicine
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig9_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig10_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-024-05641-5/MediaObjects/432_2024_5641_Fig11_HTML.png
      isPartOf:
         name:Journal of Cancer Research and Clinical Oncology
         issn:
            1432-1335
         volumeNumber:150
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sara Abdolmaleki
            affiliation:
                  name:The University of Georgia
                  address:
                     name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Alireza Aliabadi
            affiliation:
                  name:Kermanshah University of Medical Sciences
                  address:
                     name:Pharmaceutical Sciences Research Center, Health Institute, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Samad Khaksar
            affiliation:
                  name:The University of Georgia
                  address:
                     name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Cancer Research and Clinical Oncology
      issn:
         1432-1335
      volumeNumber:150
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Georgia
      address:
         name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
         type:PostalAddress
      name:Kermanshah University of Medical Sciences
      address:
         name:Pharmaceutical Sciences Research Center, Health Institute, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
         type:PostalAddress
      name:The University of Georgia
      address:
         name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sara Abdolmaleki
      affiliation:
            name:The University of Georgia
            address:
               name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Alireza Aliabadi
      affiliation:
            name:Kermanshah University of Medical Sciences
            address:
               name:Pharmaceutical Sciences Research Center, Health Institute, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
               type:PostalAddress
            type:Organization
      name:Samad Khaksar
      affiliation:
            name:The University of Georgia
            address:
               name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia
      name:Pharmaceutical Sciences Research Center, Health Institute, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
      name:Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia

External Links {🔗}(487)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Particles.js
Prism.js

CDN Services {📦}

Crossref

6.37s.

LINK . SPRINGER . COM {}